3'-azido-3'-deoxythymidine 5'phosphate has been researched along with AIDS-Associated Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Feuer, G; Ghosh, SK; Harrington, WJ; Mian, AM; Shank, NC; Toomey, NL; Wood, C | 1 |
1 other study(ies) available for 3'-azido-3'-deoxythymidine 5'phosphate and AIDS-Associated Lymphoma
Article | Year |
---|---|
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B.
Topics: Adult; Apoptosis; Apoptosis Regulatory Proteins; Dideoxynucleotides; Gene Expression; Herpesvirus 8, Human; Humans; I-kappa B Kinase; I-kappa B Proteins; Interferon-alpha; Lymphoma, AIDS-Related; Male; Membrane Glycoproteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Serine-Threonine Kinases; Remission Induction; RNA, Messenger; Thymine Nucleotides; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Zidovudine | 2003 |